Trial · NCT07881315
Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne
NCT07881315, Phase 4, Not yet recruiting, Allied Hospital Faisalabad
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne. Trials, record NCT07881315. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881315
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne
- NCT number
- NCT07881315
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 118 participants, estimated
- Lead sponsor
- Allied Hospital Faisalabad
- Conditions
- Acne Vulgaris
- Interventions
- Clascoterone 1% cream, Clindamycin 1% lotion, Adapalene 0.1%/benzoyl peroxide 2.5% gel
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage change in inflammatory lesion count | Baseline to week 12 | Papules and pustules counted on the face. Calculated as (baseline - week 12) ÷ baseline × 100. |
| Secondary | Percentage change in non-inflammatory lesion count | Open and closed comedones counted on the face. Calculated as (baseline - week 12) ÷ baseline × 100. | |
| Secondary | Percentage change in total lesion count | Baseline to week 12 | Inflammatory plus non-inflammatory lesions counted on the face. Calculated as (baseline - week 12) ÷ baseline × 100. |
| Secondary | IGA success | Week 12 | Proportion of participants with Investigator's Global Assessment (IGA) of 0 (clear) or 1 (almost clear) and at least a two-grade improvement from baseline, on the 0-4 scale |
| Secondary | Local tolerability | Weeks 4, 8 and 12 | Erythema, scaling, dryness and burning/stinging, each graded 0 (none) to 3 (severe) by the investigator. |
| Secondary | Number of participants with adverse events | Baseline to week 12 | Any adverse event reported or observed during treatment, recorded at each visit. |
| Secondary | Patient satisfaction | Week 12 | Rated by the participant on a five-point scale from very dissatisfied to very satisfied |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07881315
GET https://conductscience.org/api/trials/v1/NCT07881315/registered